Tirzepatide vs Epithalon
A comprehensive, data-driven comparison of Tirzepatide (Mounjaro) and Epithalon (Epitalon). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | Tirzepatide Mounjaro, Zepbound | Epithalon Epitalon, Epithalone |
|---|---|---|
| FDA Status | FDA Approved | Not submitted |
| Category | Weight Loss | Anti-Aging |
| Primary Use | Type 2 diabetes, chronic weight management, and obstructive sleep apnea | Anti-aging and longevity research |
| Weight Loss % | 22.5% | N/A |
| Monthly Cost | $1,100 - $1,100/mo | $40 - $80/mo |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Typical Dose | 15mg weekly (max dose) | 5-10mg per cycle (10-20 days, 2-3x per year) |
| Frequency | Weekly | Cyclical |
| Mechanism | Dual GIP/GLP-1 receptor agonist that enhances insulin secretion, reduces glucagon, slows gastric emptying, and decreases appetite | Tetrapeptide that may activate telomerase enzyme to lengthen telomeres and potentially extend cellular lifespan |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | High | Emerging |
| Clinical Trial Phase | Approved | N/A |
Key Differences
- 1Tirzepatide is FDA-approved, while Epithalon is currently not submitted.
- 2Tirzepatide has clinical weight loss data (22.5%), while Epithalon is not primarily indicated for weight loss.
- 3Epithalon is generally more affordable ($40 - $80/mo) compared to Tirzepatide ($1,100 - $1,100/mo).
- 4Tirzepatide is dosed weekly, while Epithalon is cyclical.
- 5Tirzepatide has high-quality evidence, while Epithalon has emerging-quality evidence.
- 6They belong to different categories: Tirzepatide (Weight Loss) vs Epithalon (Anti-Aging).
Which Is Better For...
Tirzepatide
Those seeking an FDA-approved treatment with established safety data
Epithalon
More budget-friendly option with lower monthly costs
Epithalon
More convenient dosing schedule (cyclical)
Epithalon
Fewer commonly reported side effects
Tirzepatide
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| Tirzepatide | $1,100 - $1,100/mo | FDA Approved | Eli Lilly |
| Epithalon | $40 - $80/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
Tirzepatide works via Dual GIP/GLP-1 receptor agonist that enhances insulin secretion, reduces glucagon, slows gastric. Epithalon works via Tetrapeptide that may activate telomerase enzyme to lengthen telomeres and potentially extend. They differ in FDA approval status, efficacy data, and cost.
Tirzepatide has demonstrated 22.5% average weight loss in clinical trials. Epithalon is not primarily used for weight loss.
Tirzepatide typically costs $1,100 - $1,100/mo, while Epithalon costs $40 - $80/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
Tirzepatide is FDA-approved. Epithalon is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of Tirzepatide include Nausea, Diarrhea, Decreased appetite. Common side effects of Epithalon include Injection site reactions, Mild drowsiness, Vivid dreams. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
Tirzepatide is a dual-action peptide approved by the FDA as Mounjaro for type 2 diabetes and Zepbound for weight management. In December 2024, Zepbound became the first and only medication approved fo...
View Full Tirzepatide GuideEpithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) researched primarily in Russia for its potential anti-aging properties. The proposed mechanism involves activation of telomerase, an enzyme that...
View Full Epithalon GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between Tirzepatide and Epithalon should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.